Last 44 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -7.22 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 158.83 | 36.84 | 3.16 | 7.53 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | +2675.8% | +313.9% | -14.6% | +256.1% | |
| P/S Ratio | 2.04 | 1.68 | 1.68 | 1.73 | 2.43 | 2.07 | 1.87 | 1.77 | 1.86 | 2.30 | 2.08 | 2.50 | 3.05 | 2.37 | 4.07 | 3.48 | 3.40 | 2.78 | 3.39 | 1.52 | 3.12 |
| — | -18.5% | -10.2% | -2.7% | +30.6% | -10.3% | -9.9% | -29.2% | -39.1% | -2.8% | -48.9% | -28.1% | -10.4% | -14.9% | +19.9% | +128.9% | +9.2% | -9.5% | -26.7% | -26.4% | +161.4% | |
| P/B Ratio | 0.66 | 0.62 | 0.58 | 0.47 | 0.73 | 0.62 | 0.55 | 0.46 | 0.50 | 0.58 | 0.52 | 0.57 | 0.76 | 0.64 | 0.87 | 0.73 | 0.73 | 0.92 | 1.30 | 1.48 | 2.69 |
| — | -0.2% | +4.6% | +1.3% | +45.7% | +6.5% | +5.4% | -19.1% | -34.0% | -8.4% | -40.1% | -21.1% | +4.6% | -30.7% | -32.7% | -51.1% | -73.0% | -65.8% | -58.0% | -60.0% | +8.9% | |
| P/FCF | — | 1.42 | — | 64.78 | — | 34.35 | — | — | 6.66 | — | — | 50.31 | 18.19 | 37.73 | — | — | 8.09 | 19.17 | 54.04 | 2.66 | 11.03 |
| — | -95.9% | — | — | — | — | — | — | -63.4% | — | — | — | +124.8% | +96.8% | — | — | -26.7% | +307.0% | +456.3% | -20.6% | +246.4% | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | 27.19 | — | — | — | 25.27 | 18.72 | 1.96 | 4.84 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +7.6% | — | — | — | +528.8% | +174.4% | -25.8% | +228.8% | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | 26.02 | — | — | — | 562.56 | 25.22 | 2.00 | 4.96 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -95.4% | — | — | — | +13665.4% | +276.6% | -24.6% | +235.8% |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 40.6% | 35.3% | 30.1% | 30.2% | 39.1% | 42.2% | 42.1% | 38.6% | 41.8% | 37.3% | 37.3% | 34.3% | 35.8% | 47.0% | 30.3% | 28.4% | 19.2% | 43.6% | 52.1% | 75.7% | 75.3% |
| — | -16.4% | -28.6% | -21.7% | -6.4% | +13.2% | +12.9% | +12.6% | +16.8% | -20.7% | +23.0% | +20.6% | +86.5% | +7.8% | -41.8% | -62.5% | -74.5% | -46.1% | -32.1% | -4.6% | -8.7% | |
| Operating Margin | -28.2% | -14.8% | -39.7% | -48.7% | -43.5% | -18.3% | -24.1% | -26.9% | -21.2% | -23.8% | -26.6% | -33.8% | -214.3% | 0.3% | -29.2% | -37.5% | -54.0% | 0.3% | 10.2% | 63.1% | 59.9% |
| — | +19.2% | -64.8% | -80.6% | -105.4% | +23.3% | +9.5% | +20.3% | +90.1% | -9520.6% | +8.8% | +9.9% | -297.0% | -24.2% | -385.8% | -159.5% | -190.1% | -99.5% | -84.1% | -15.1% | -21.7% | |
| Net Margin | -18.8% | -14.5% | -34.6% | -34.9% | -28.1% | -7.9% | -23.2% | -15.7% | -7.7% | -20.4% | -12.3% | -20.9% | -181.8% | -15.5% | -16.5% | -23.2% | -35.2% | 1.6% | 9.2% | 48.1% | 41.5% |
| — | -85.1% | -49.2% | -122.4% | -263.7% | +61.5% | -89.0% | +24.8% | +95.7% | -31.9% | +25.9% | +10.0% | -416.4% | -1051.3% | -279.8% | -148.2% | -184.9% | -97.0% | -82.3% | -13.9% | -26.5% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -5.4% | -1.3% | -2.9% | -2.3% | -2.1% | -0.6% | -1.7% | -1.0% | -0.5% | -1.3% | -0.8% | -1.2% | -10.7% | -1.0% | -0.9% | -1.2% | -1.9% | 0.1% | 0.9% | 12.4% | 9.4% |
| — | -124.3% | -70.6% | -125.4% | -304.3% | +54.3% | -119.7% | +14.1% | +95.1% | -24.7% | +12.9% | +1.4% | -472.8% | -882.9% | -200.9% | -109.7% | -119.8% | -98.9% | -90.5% | -57.6% | -78.5% | |
| ROA | -5.0% | -1.2% | -2.6% | -2.1% | -1.9% | -0.5% | -1.6% | -1.0% | -0.5% | -1.2% | -0.7% | -1.1% | -9.9% | -1.0% | -0.8% | -1.1% | -1.7% | 0.1% | 0.8% | 11.2% | 8.4% |
| — | -121.6% | -66.9% | -120.4% | -301.9% | +53.9% | -122.8% | +13.0% | +95.1% | -23.0% | +14.0% | +1.6% | -478.8% | -905.8% | -204.3% | -109.9% | -120.3% | -98.9% | -89.9% | -52.5% | -76.1% | |
| ROIC | -6.4% | -1.1% | -2.5% | -2.5% | -2.6% | -1.1% | -1.4% | -1.4% | -1.1% | -1.2% | -1.3% | -1.5% | -10.2% | 0.0% | -1.2% | -1.5% | -2.3% | 0.0% | 0.9% | 15.1% | 12.1% |
| — | +5.5% | -79.2% | -79.1% | -134.7% | +4.8% | -7.6% | +9.6% | +89.0% | -8943.3% | -7.5% | -0.9% | -337.7% | -41.0% | -238.2% | -110.0% | -119.2% | -99.8% | -91.0% | -56.1% | -77.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.01 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 |
| — | -92.7% | +42.4% | +39.0% | -7.5% | -15.6% | -39.3% | -38.0% | -44.3% | +248.2% | +203.0% | -32.3% | -56.1% | -85.7% | -77.2% | +1.1% | +68.0% | -27.1% | -33.5% | -14.5% | -34.4% | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | 0.44 | — | — | — | 2.01 | 0.98 | 0.10 | 0.14 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | -78.4% | — | — | — | +1328.2% | +353.4% | +82.3% | +96.9% | |
| Current Ratio | 6.48 | 9.94 | 6.34 | 5.31 | 6.48 | 7.01 | 6.01 | 6.32 | 4.85 | 4.41 | 5.27 | 5.09 | 6.96 | 8.95 | 8.15 | 7.09 | 7.13 | 6.79 | 5.29 | 5.40 | 5.81 |
| — | +42.0% | +5.5% | -15.9% | +33.6% | +58.7% | +14.1% | +24.2% | -30.3% | -50.7% | -35.4% | -28.2% | -2.4% | +31.8% | +53.9% | +31.2% | +22.6% | +60.5% | +13.5% | +61.0% | +44.4% | |
| Quick Ratio | 6.35 | 9.94 | 6.18 | 5.18 | 6.35 | 6.87 | 5.88 | 6.19 | 4.74 | 4.30 | 5.18 | 5.00 | 6.88 | 8.87 | 8.06 | 7.03 | 7.08 | 6.72 | 5.20 | 5.33 | 5.70 |
| — | +44.8% | +4.9% | -16.3% | +34.2% | +59.8% | +13.7% | +23.8% | -31.1% | -51.6% | -35.8% | -28.8% | -2.9% | +32.0% | +55.1% | +32.0% | +24.3% | +64.6% | +16.8% | +65.2% | +46.1% | |
| Interest Coverage | -932.67 | -1905.57 | -502.22 | -1527.12 | -217.46 | -218.39 | -1264.82 | -836.36 | -37.31 | -1322.71 | — | — | — | 99.00 | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 44 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying FLGT stock.
Fulgent Genetics, Inc.'s current P/E is -7.2x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Fulgent Genetics, Inc.'s current operating margin is -28.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Fulgent Genetics, Inc.'s business trajectory between earnings reports.